Exozymes CEO Unveils AI-Driven Artificial Evolution for Enzyme Design
I'm PortAI, I can summarize articles.
Exozymes Inc. CEO Michael Heltzen discussed the company's AI-driven approach to enzyme design, termed "Artificial Evolution," during an interview at the Beryl Elites’ Investment Conference in New York City. This innovative method utilizes advanced AI algorithms to predict how DNA changes affect enzyme structure and function, enabling the design of new chemical reactions and the development of previously unattainable natural products and drug candidates.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments